This site is intended for healthcare professionals

Arcutis initiates pivotal phase III clinical trials for topical roflumilast cream (ARQ 151) as a potential treatment for atopic dermatitis.

Read time: 1 mins
Last updated:28th Jun 2021
Published:14th Jan 2021
Condition: Atopic Dermatitis (Eczema)
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest